Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells

• Katie Matthews,

  Affiliation Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Nancy P. Y. Chung,

  Affiliation Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Per Johan Klasse,

  Affiliation Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Magda Moutaftsi,

  Affiliation HIV Vaccine Initiative at Bill and Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Darrick Carter,

  Affiliation Infectious Diseases Research Institute (IDRI), Seattle, Washington, United States of America

  ⨯
• André M. Salazar,

  Affiliation Oncovir, Inc., Washington D.C., United States of America

  ⨯
• Steven G. Reed,

  Affiliation Infectious Diseases Research Institute (IDRI), Seattle, Washington, United States of America

  ⨯
• Rogier W. Sanders,

  Affiliations Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America, Laboratory for Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• John P. Moore

  * E-mail: jpm2003@med.cornell.edu

  Affiliation Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯